{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:09Z","timestamp":1788532029517,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Health Research Project of Hunan Provincial Health Commission","award":["20253997"],"award-info":[{"award-number":["20253997"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The incidence of thyroid cancer has increased globally over recent decades, while mortality has remained stable or declined. However, integrated assessments of temporal trends, age-period-cohort (APC) effects, and future projections, particularly in BRICS countries, are limited. This study evaluated long-term incidence trends of thyroid cancer worldwide and across BRICS nations from 1990 to 2021 and projected future patterns. Data were derived from the Global Burden of Disease 2021 study. Age-standardized incidence rates and estimated annual percentage changes were calculated to assess temporal trends. Countries were grouped using hierarchical cluster analysis. Conventional APC analysis and Bayesian APC models were applied to identify dominant temporal effects and project incidence from 2022 to 2041 by sex and age group. Globally, the age-standardized incidence rate of thyroid cancer increased from 2.06 to 2.91 per 100,000 population between 1990 and 2021 (estimated annual percentage change\u2005=\u20051.25%). Considerable heterogeneity was observed among BRICS countries. China and India experienced the fastest increases, with particularly steep rises among Chinese males. The Russian Federation showed persistently high but relatively stable incidence, while Brazil and South Africa exhibited moderate upward trends. APC analyses indicated that period effects predominated globally and in Brazil and South Africa, cohort effects were dominant in China and India, and age effects were more pronounced in the Russian Federation. Bayesian APC projections suggested a continued global increase in thyroid cancer incidence, especially among middle-aged and older women, with sustained female predominance. Thyroid cancer incidence is projected to rise further worldwide, with heterogeneous APC-driven patterns across BRICS countries, underscoring the need for targeted surveillance and prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048828","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:00:47Z","timestamp":1778896847000},"page":"e48828","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Temporal trends in thyroid cancer incidence worldwide and in BRICS countries: A Bayesian age-period-cohort analysis and 20-year projections based on GBD 2021 data"],"prefix":"10.1097","volume":"105","author":[{"given":"Lumei","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Central Hospital of Yongzhou, Yongzhou, Hunan, China"},{"name":"Department of Pharmacy, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Central Hospital of Yongzhou, Yongzhou, Hunan, China"},{"name":"Department of Pharmacy, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Central Hospital of Yongzhou, Yongzhou, Hunan, China"},{"name":"Department of Pharmacy, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Central Hospital of Yongzhou, Yongzhou, Hunan, China"},{"name":"Department of Pharmacy, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3000-3328","authenticated-orcid":false,"given":"Guansheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Central Hospital of Yongzhou, Yongzhou, Hunan, China"},{"name":"Department of Anesthesiology, Yongzhou Hospital Affiliated to University of South China, Yongzhou, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"873027","DOI":"10.3389\/fendo.2022.873027","article-title":"Thyroid cancer and COVID-19: prospects for therapeutic approaches and drug development.","volume":"13","author":"Qu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study.","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/hed.25029","article-title":"Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis.","volume":"40","author":"Sanabria","year":"2018","journal-title":"Head Neck"},{"key":"R4-20260904","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022.","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.29251","article-title":"Thyroid cancer mortality and incidence: a global overview.","volume":"136","author":"La Vecchia","year":"2015","journal-title":"Int J Cancer"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer.","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/cncr.26587","article-title":"MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.","volume":"118","author":"Vriens","year":"2012","journal-title":"Cancer"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1002\/cam4.3970","article-title":"The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: a systematic analysis for the Global Burden of Disease Study.","volume":"10","author":"Zhai","year":"2021","journal-title":"Cancer Med"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.17305\/bb.2025.12503","article-title":"Global, regional, and national trends in thyroid cancer burden (1990\u20132021): insights from the GBD 2021 study.","volume":"25","author":"Tang","year":"2025","journal-title":"Biomol Biomed"},{"key":"R10-20260904","first-page":"04090","article-title":"Assessing and projecting the global burden of thyroid cancer, 1990\u20132030: analysis of the Global Burden of Disease Study.","volume":"14","author":"Zhao","year":"2024","journal-title":"J Glob Health"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"1100300","DOI":"10.3389\/fonc.2023.1100300","article-title":"More recent insights into the breast cancer burden across BRICS-Plus: health consequences in key nations with emerging economies using the Global Burden of Disease Study 2019.","volume":"13","author":"Mubarik","year":"2023","journal-title":"Front Oncol"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41256-023-00318-x","article-title":"The priority areas and possible pathways for health cooperation in BRICS countries.","volume":"8","author":"Liu","year":"2023","journal-title":"Glob Health Res Policy"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"e0003023","DOI":"10.1371\/journal.pgph.0003023","article-title":"The COVID-19 pandemic in BRICS: milestones, interventions, and molecular epidemiology.","volume":"4","author":"van Wyk","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"1511530","DOI":"10.3389\/fonc.2024.1511530","article-title":"The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035.","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"04131","DOI":"10.7189\/jogh.14.04131","article-title":"Thyroid cancer trends in China and its comparative analysis with G20 countries: projections for 2020\u20132040.","volume":"14","author":"Gong","year":"2024","journal-title":"J Glob Health"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12874-023-02039-8","article-title":"Comparative age-period-cohort analysis.","volume":"23","author":"Rosenberg","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","article-title":"Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040.","volume":"23","author":"Chu","year":"2025","journal-title":"World J Surg Oncol"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1186\/s12889-025-23814-w","article-title":"Global, regional, and national burden of maternal disorders, 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021.","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Public Health"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"1466428","DOI":"10.3389\/fendo.2025.1466428","article-title":"Comparison of incidence trends of early-onset and late-onset type 2 diabetes in the Asia-Pacific region, 1990\u20132021: a join point regression analysis based on the Global Burden of Disease Study 2021.","volume":"16","author":"Lin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"1644270","DOI":"10.3389\/fendo.2025.1644270","article-title":"Epidemiological study of thyroid cancer at global, regional, and national levels from 1990 to 2021: an analysis derived from the Global Burden of Disease Study 2021.","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"109245","DOI":"10.4251\/wjgo.v17.i8.109245","article-title":"Gallbladder and biliary tract cancer burden trends in Brazil, Russian Federation, India, China, and South Africa in 1990\u20132021.","volume":"17","author":"Cui","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12889-024-21192-3","article-title":"Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"25","author":"Jiang","year":"2025","journal-title":"BMC Public Health"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/1759-7714.14099","article-title":"Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.","volume":"12","author":"Bao","year":"2021","journal-title":"Thorac Cancer"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5144\/0256-4947.2019.345","article-title":"Trends in thyroid carcinoma among thyroidectomy patients: a 12-year multicenter study.","volume":"39","author":"Doubi","year":"2019","journal-title":"Ann Saudi Med"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"707233","DOI":"10.3389\/fendo.2021.707233","article-title":"Secular trends in the epidemiologic patterns of thyroid cancer in China over three decades: an updated systematic analysis of Global Burden of Disease Study 2019 data.","volume":"12","author":"Li","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"04113","DOI":"10.7189\/jogh.15.04113","article-title":"Global landscape of early-onset thyroid cancer: current burden, temporal trend and future projections on the basis of GLOBOCAN 2022.","volume":"15","author":"Jin","year":"2025","journal-title":"J Glob Health"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"1385836","DOI":"10.3389\/fendo.2024.1385836","article-title":"Machine learning to predict the occurrence of thyroid nodules: towards a quantitative approach for judicious utilization of thyroid ultrasonography.","volume":"15","author":"Liang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1210\/js.2017-00097","article-title":"Rising thyroid cancer incidence in southern India: an epidemic of overdiagnosis?","volume":"1","author":"Mathew","year":"2017","journal-title":"J Endocr Soc"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1210\/clinem\/dgaa192","article-title":"Thyroid cancer incidence in India between 2006 and 2014 and impact of overdiagnosis.","volume":"105","author":"Panato","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HP.0b013e3181c910dd","article-title":"Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident.","volume":"99","author":"Drozdovitch","year":"2010","journal-title":"Health Phys"},{"key":"R31-20260904","first-page":"299","article-title":"Thyroid cancer in regions most contaminated after the Chernobyl disaster.","volume":"14","author":"Janiak","year":"2024","journal-title":"J Biomed Phys Eng"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clon.2011.01.510","article-title":"The Chernobyl accident\u2013an epidemiological perspective.","volume":"23","author":"Cardis","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"e0137226","DOI":"10.1371\/journal.pone.0137226","article-title":"Major factors affecting incidence of childhood thyroid cancer in Belarus after the Chernobyl accident: do nitrates in drinking water play a role?","volume":"10","author":"Drozd","year":"2015","journal-title":"PLoS One"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1089\/thy.2012.0532","article-title":"Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997\u20132008.","volume":"23","author":"Veiga","year":"2013","journal-title":"Thyroid"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","article-title":"Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013\u201317 in 63 countries worldwide: a population-based study.","volume":"12","author":"Li","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1186\/s12885-020-07597-4","article-title":"Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.","volume":"20","author":"Kang","year":"2020","journal-title":"BMC Cancer"},{"key":"R37-20260904","first-page":"119","article-title":"Modifiable risk factors for thyroid cancer: lifestyle and residence environment.","volume":"75","author":"Shen","year":"2024","journal-title":"Endokrynol Pol"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3390\/ijerph17113821","article-title":"Uterine fibroids increase the risk of thyroid cancer.","volume":"17","author":"Sun","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12885-024-12376-6","article-title":"Causal association of sleep traits with the risk of thyroid cancer: a Mendelian randomization study.","volume":"24","author":"Zong","year":"2024","journal-title":"BMC Cancer"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1017\/S0007114521000593","article-title":"Insufficient iodine nutrition may affect the thyroid cancer incidence in China.","volume":"126","author":"Fan","year":"2021","journal-title":"Br J Nutr"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1186\/s12889-025-21960-9","article-title":"Global trend and disparity in the burden of thyroid cancer attributable to high body-mass index from 1990 to 2021 and projection to 2049: a systematic analysis based on the Global Burden of Disease Study 2021.","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Public Health"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/aje\/kwv127","article-title":"Risk of thyroid follicular adenoma among children and adolescents in Belarus exposed to iodine-131 after the Chornobyl accident.","volume":"182","author":"Zablotska","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","article-title":"Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy.","volume":"181","author":"LeClair","year":"2021","journal-title":"JAMA Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:01:04Z","timestamp":1788530464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":44,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048828","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2026-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}